About
Emergent Biosolutions Inc (NYSE:EBS) — investor relations, events, news, and company updates on 6ix.
Latest News
Today
Emergent BioSolutions and Substipharm Biologics Announce Strategic Manufacturing Partnership to Support Japanese Encephalitis Vaccine in the United States
Apr 16 2026
Emergent BioSolutions to Report First Quarter 2026 Financial Results on April 30, 2026
Apr 9 2026
Emergent BioSolutions Partners with British Columbia to Supply NARCAN® Nasal Spray for the Launch of the Expanded BC Take Home Naloxone Program
Apr 7 2026
Emergent BioSolutions Launches New NARCAN® Nasal Spray Carrying Case and Multipacks Alongside College Campus Outreach to Expand Opioid Overdose Preparedness
Apr 2 2026
Emergent BioSolutions Participates in Upcoming International Preparedness Conferences
Financials
Revenue
$742.9 M
Market Cap
$426.07 M
P/E Ratio
8.85
EPS
0.93
Google Übersetzer